Advanced Health Intelligence Management

Management criteria checks 2/4

Advanced Health Intelligence's CEO is Scott Montgomery, appointed in Dec 2022, has a tenure of 1.33 years. total yearly compensation is A$364.94K, comprised of 58.3% salary and 41.7% bonuses, including company stock and options. directly owns 1.76% of the company’s shares, worth A$396.97K. The average tenure of the management team and the board of directors is 5 years and 2.2 years respectively.

Key information

Scott Montgomery

Chief executive officer

AU$364.9k

Total compensation

CEO salary percentage	58.3%
CEO tenure	1.3yrs
CEO ownership	1.8%
Management average tenure	5yrs
Board average tenure	2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Scott Montgomery's remuneration changed compared to Advanced Health Intelligence's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-AU$17m
Sep 30 2023	n/a	n/a	-AU$15m
Jun 30 2023	AU$365k	AU$213k	-AU$13m

Compensation vs Market: Scott's total compensation ($USD237.45K) is about average for companies of similar size in the Australian market ($USD292.58K).

Compensation vs Earnings: Insufficient data to compare Scott's compensation with company performance.

CEO

Scott Montgomery (41 yo)

1.3yrs

Tenure

AU$364,938

Compensation

Mr. Scott Montgomery serves as Chief Executive Officer & Executive Director of Advanced Health Intelligence Ltd. (formerly known as Advanced Human Imaging Limited) since December 1, 2022. Mr Montgomery co-...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Scott Montgomery	CEO & Executive Director	1.3yrs	AU$364.94k	1.76% A$ 397.0k
Katherine Iscoe	Co-Founder & Executive Director	10.3yrs	AU$284.24k	13.96% A$ 3.2m
Simon Durack	CFO & Company Secretary	2.1yrs	AU$277.31k	no data
Vlado Bosanac	Founder & Head of Strategy	11.3yrs	AU$6.78m	0% A$ 0
Terence Stupple	Chief Technology Officer	8.3yrs	no data	1.73% A$ 391.0k
Riaan Conradie	Chief Science Officer	no data	no data	no data
Anita Swan	Marketing Director	8yrs	no data	no data
Nadine Amesz	Head of Operations	no data	no data	no data
Kevin Baum	Chief Product Officer	1.3yrs	no data	no data
Dylan Garnett	Chief Innovation Officer	1.3yrs	no data	no data

5.0yrs

Average Tenure

47yo

Average Age

Experienced Management: AHI's management team is seasoned and experienced (5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Scott Montgomery	CEO & Executive Director	1.3yrs	AU$364.94k	1.76% A$ 397.0k
Katherine Iscoe	Co-Founder & Executive Director	2.2yrs	AU$284.24k	13.96% A$ 3.2m
Peter Goldstein	Non-Executive Independent Director	1.8yrs	AU$53.43k	no data
Michael Melby	Independent Non-Executive Director	6.5yrs	AU$36.00k	no data
Nicholas John Prosser	Chairman	6yrs	AU$41.31k	2.96% A$ 668.4k
Koon Poh Low	Independent Non-Executive Director	3.8yrs	AU$36.00k	0.12% A$ 27.6k
Soak Yee	Independent Non-Executive Director	1.3yrs	AU$18.00k	no data

2.2yrs

Average Tenure

48yo

Average Age

Experienced Board: AHI's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Advanced Health Intelligence Management

Management criteria checks 2/4

Key information

Recent management updates

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Recent updates

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.16

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.59

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

New 90-day high - AU$0.29

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age